Email:
michaelhsiung@arkpharmtech.com
po@arkpharmtech.com
|
| Product Name | (2R,3R,4R,5R,6S)-6-(((2R,4R,4aR,6aR,7S,9R,11aS,11bR)-4-carboxy-7-hydroxy-11b-methyl-8-methylenetetradecahydro-6a,9-methanocyclohepta[a]naphthalen-2-yl)oxy)-2-(hydroxymethyl)-5-((3-methylbutanoyl)oxy)tetrahydro-2H-pyran-3,4-diyl bis(sulfate) |
| Synonyms | Atractyloside potassium salt;19-Norkaur-16-en-18-oicacid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-b-D-glucopyranosyl]oxy]-,dipotassium sal;Atractyloside (potassium salt);(2beta,15alpha)-15-Hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-beta-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic acid dipotassium salt;ATR, 2K;ATRACTYLOSIDE, DIPOTASSIUM SALT;ATRACTYLOSIDE, DIPOTASSIUM SALT, ATRACTYLIS GUMMIFERA;19-Norkaur-16-en-18-oic acid deriv. 1H-2,10a-Ethanophenanthrene;(2β,15α)-15-Hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-19-Norkaur-16-en-18-oic Acid Dipotassium Salt;19-Norkaur-16-en-18-oicacid, 15-hydroxy-2-[[2-O-(3-Methyl-1-oxobutyl)-3,4-di-O-sulfo-b-D-glucopyranosyl]oxy]-,dipotassiuM salt, (2b,15a)- (9CI);19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-.beta.-D-glucopyranosyloxy-, dipotassium salt, (2.beta.,15.alpha.)-;Atractyloside dipotassium salt, >=98%;Atractyloside potassium salt;atractyloside;ATRACTYLOSIDE POTASSIUM;Prestwick_47;SPECTRUM1502117;and adenosine nucleotide transfer;HMS501D16;HMS1570C16 |
| Catalog No. | H-049900 |
| CAS No. | 102130-43-8 |
| Molecular Formula | C30H44K2O16S2 |
| Molecular Weight | 802.9874 |
| Smile Code | [H][C@@]12[C@H](C(O)=O)C[C@@H](O[C@H]3O[C@H](CO)[C@@H](OS(=O)([O-])=O)[C@H](OS(=O)([O-])=O)[C@H]3OC(CC(C)C)=O)C[C@@]1(C)[C@@]4([H])[C@@](C[C@H]5CC4)([C@@H](O)C5=C)CC2.[K+].[K+] |
| InChI | |
| EINECS | |
| Density | |
| Melting point | |
| Boiling point | |
| Refractive index | |
| Water solubility | |
| Hazard Symbols | |
| Risk Codes | |
| Safety Description |